REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmanext Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Pharmanext Kft. Profile Updated: April 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Hungarian Download a sample report

Pharmanext Kft. is based in Hungary. The head office is in Budapest. The enterprise operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Pharmanext Kft. was incorporated on August 15, 2019. It currently has a total number of 1 - 10 (2025) employees. From the latest financial highlights, Pharmanext Kft. reported a net sales revenue increase of 9.55% in 2025. There was a total growth of 8.8% in Pharmanext Kft.’s total assets over the same period. The net profit margin of Pharmanext Kft. decreased by 1.49% in 2025.

Headquarters
Stahly utca 2/A. 3. emelet 3.
Budapest; Budapest; Postal Code: 1085

Contact Details: Purchase the Pharmanext Kft. report to view the information.

Website: http://www.pharmanext.hu

Basic Information
Total Employees:
Purchase the Pharmanext Kft. report to view the information.
Financial Auditors:
Purchase the Pharmanext Kft. report to view the information.
Incorporation Date:
August 15, 2019
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Hello Pharma Kft.
Company Performance
Financial values in the chart are available after Pharmanext Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
9.55%
Total Operating Revenue
9.7%
Operating Profit
-8.03%
EBITDA
-8.33%
Net Profit/Loss for the Period
-10.5%
Total Assets
8.8%
Total Equity
19.34%
Operating Profit Margin
-1.5%
Net Profit Margin
-1.49%
Return on Equity (ROE)
-15.02%
Debt / Equity
19.98%
Quick Ratio
-0.16%
Cash Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?